The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with ...

Spring is finally here, and for many of us that brings the joy of returning to outdoor activities, planning summer vacations, ...

The FDA has approved Dupixent as the first new targeted therapy in over ten years for chronic spontaneous urticaria in patients aged 12 and older who remain symptomatic despite antihistamine treatment ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

On the other hand, in the fall, weed pollen such as swine grass and mugwort causes allergic reactions.Interestingly, ...

Every year, allergy season means the sniffles, congestion, itchy, runny eyes and constant sneezing. And every year, you ...

The guidelines for treating seasonal allergic rhinitis with medications suggest that you use intranasal corticosteroids ...

Each spring, summer, and fall, different plants like grass, trees, or weeds release pollen to fertilize plants of the same species. But these tiny bits of pollen can be the culprit of your seasonal ...

Immunologists break down the options for treating seasonal allergies depending on symptoms and severity. They share the most ...

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...